768 results on '"Han, Seol‐Heui"'
Search Results
2. Blood-brain barrier breakdown is linked to tau pathology and neuronal injury in a differential manner according to amyloid deposition
3. Magnetic susceptibility in the deep gray matter may be modulated by apolipoprotein E4 and age with regional predilections: a quantitative susceptibility mapping study
4. Sarcopenia in patients with dementia: correlation of temporalis muscle thickness with appendicular muscle mass
5. Synergistic efficacy and diminished adverse effect profile of composite treatment of several ADHD medications
6. Hospital adverse outcomes of the elderly in a tertiary referral hospital: A prospective cohort study of 9,586 admissions
7. Future Therapeutic Strategies for Alzheimer's Disease: Focus on Behavioral and Psychological Symptoms.
8. GSP1-111 Modulates the Microglial M1/M2 Phenotype by Inhibition of Toll-like Receptor 2: A Potential Therapeutic Strategy for Depression.
9. Associations of truncal body composition with cognitive status in patients with dementia
10. Incidence of osteoporosis and ambient air pollution in South Korea: a population-based retrospective cohort study
11. Exposure to ambient fine particles and neuropsychiatric symptoms in cognitive disorder: A repeated measure analysis from the CREDOS (Clinical Research Center for Dementia of South Korea) study
12. Myelin loss in white matter hyperintensities and normal-appearing white matter of cognitively impaired patients: a quantitative synthetic magnetic resonance imaging study
13. Motor cortex hypointensity on susceptibility-weighted imaging: a potential imaging marker of iron accumulation in patients with cognitive impairment
14. Early Identification of Risk Factors for Mobility Decline among Hospitalized Older Patients
15. Agmatine rescues autistic behaviors in the valproic acid-induced animal model of autism
16. The Easy Dysphagia Symptom Questionnaire (EDSQ): a new dysphagia screening questionnaire for the older adults
17. Muscle profile and cognition in patients with Alzheimer’s disease dementia
18. Comparison of neuropsychological profiles in patients with Alzheimer's disease and mixed dementia
19. Disruption of neuronal nitric oxide synthase dimerization contributes to the development of Alzheimer’s disease: Involvement of cyclin-dependent kinase 5-mediated phosphorylation of neuronal nitric oxide synthase at Ser293
20. Transient global amnesia: Only in already disrupted neuronal integrity of memory network?
21. Extrapyramidal Signs and Cognitive Subdomains in Alzheimer Disease
22. Prediction of cognitive impairment via deep learning trained with multi-center neuropsychological test data
23. High sucrose consumption during pregnancy induced ADHD-like behavioral phenotypes in mice offspring
24. Group- and Home-Based Cognitive Intervention for Patients with Mild Cognitive Impairment : A Randomized Controlled Trial
25. Diabetes augments cognitive dysfunction in chronic cerebral hypoperfusion by increasing neuronal cell death: Implication of cilostazol for diabetes mellitus-induced dementia
26. sj-pdf-1-jcb-10.1177_0271678X231180035 - Supplemental material for Blood-brain barrier breakdown is linked to tau pathology and neuronal injury in a differential manner according to amyloid deposition
27. Effects of donepezil, an acetylcholinesterase inhibitor, on neurogenesis in a rat model of vascular dementia
28. Minoxidil Regulates Aging-Like Phenotypes in Rat Cortical Astrocytes In Vitro
29. Possible role for blood‐brain barrier disruption in patients with Alzheimer’s disease spectrum and non‐Alzheimer’s disease pathological changes
30. Valproic acid increases NO production via the SH-PTP1–CDK5–eNOS-Ser116 signaling cascade in endothelial cells and mice
31. Do Alzheimer's disease (AD) and subcortical ischemic vascular dementia (SIVD) progress differently?
32. A New Classification System for Ischemia Using a Combination of Deep and Periventricular White Matter Hyperintensities
33. Unmet healthcare needs of elderly people in Korea
34. Novel Therapeutics for Treating Sleep Disorders: New Perspectives on Maydis stigma
35. Corrigendum to “Glucose deprivation reversibly down-regulates tissue plasminogen activator via proteasomal degradation in rat primary astrocytes” [Life Sci. 92 (2013) 929–937]
36. Neuropsychiatric predictors of conversion to dementia both in patients with amnestic mild cognitive impairment and those with subcortical vascular MCI
37. Glucose deprivation reversibly down-regulates tissue plasminogen activator via proteasomal degradation in rat primary astrocytes
38. Neuroprotective effects of valproic acid against hemin toxicity: Possible involvement of the down-regulation of heme oxygenase-1 by regulating ubiquitin–proteasomal pathway
39. Effects of Korean red ginseng extracts on neural tube defects and impairment of social interaction induced by prenatal exposure to valproic acid
40. Behavioural and neuropsychiatric disturbance in three clinical subtypes of frontotemporal dementia: A Clinical Research Center for Dementia of South Korea‐FTD Study
41. MeCP2 Modulates Sex Differences in the Postsynaptic Development of the Valproate Animal Model of Autism
42. A Multicentre, Randomised, Open-Label, Prospective Study to Estimate the Add-On Effects Of Memantine as Ebixa® Oral Pump (Solution) on Language in Patients with Moderate to Severe Alzheimer's Disease Already Receiving Donepezil (ROMEO-AD).
43. Prenatal exposure to valproic acid increases the neural progenitor cell pool and induces macrocephaly in rat brain via a mechanism involving the GSK-3β/β-catenin pathway
44. Proteinase 3 Induces Neuronal Cell Death Through Microglial Activation
45. Depressive-Like Behaviors in a Rat Model of Chronic Cerebral Hypoperfusion
46. Whole Exome Sequencing Reveals a Novel APOE Mutation in a Patient With Sporadic Early-Onset Alzheimer's Disease
47. Biphasic regulation of tissue plasminogen activator activity in ischemic rat brain and in cultured neural cells: Essential role of astrocyte-derived plasminogen activator inhibitor-1
48. Urine Neural Thread Protein Measurements in Alzheimer Disease
49. Pyramidal and extrapyramidal scale (PEPS): A new scale for the assessment of motor impairment in vascular cognitive impairment associated with small vessel disease
50. A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase IIb Clinical Study to Evaluate the Safety and Efficacy of DHP1401 in Patients with Mild to Moderate Alzheimer’s Disease Treated with Donepezil: DHP1401 Randomized Trial in Mild to Moderate Alzheimer’s Disease (DRAMA)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.